ASX
Cynata Therapeutics Limited
CYP:ASX•Healthcare
Sensitive ASX Announcement
Ethics Committee Approval for Proposed aGvHD Phase 2 Trial
Published: 12/04/23, 09:37am (AEST)•1 pages